| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |